by

CTech 24/7

More stories in CTech

Can-Fite

5 stories about Can-Fite

Can-Fite’s Private Placement Could be Key to Avoiding a Hostile Takeover
11.09.19|Tzally GreenbergNYSE and Tel Aviv-listed Israeli pharmaceutical company Can-Fite announced on Tuesday a collaboration agreement with Tel Aviv-listed medical cannabis cannabis company Univo, which will receive a 16.6% stake in the former
Can-Fite BioPharma Signs South Korean Distribution Agreement for Psoriasis Treatment Drug
04.08.19|Adi PickThe agreement, signed with pharma company Kyongbo Pharm, is contingent upon regulatory approval for the drug, currently in phase 3 clinical trials
Can-Fite BioPharma Receives $1 Million From CKD Pharmaceuticals as Part of Expanded Agreement
16.04.19|CTechIsrael-based Can-Fite expanded its distribution agreement with the South Korean company in February, and is entitled to up to $5 million more in milestones
Can-Fite BioPharma to Raise $3.2 Million in Direct Offering
04.04.19|CTechThe NYSE and Tel Aviv-listed company develops small molecule drugs used in the treatment of liver and inflammatory diseases and cancer
China’s CMS Medical Signs Multi-Million Dollar Deal With Israeli Pharma Company Can-Fite
07.08.18|Amarelle WenkertNew York-listed Can-Fite develops small molecule drugs used in the treatment of liver and inflammatory diseases and cancer

About CTech Terms of Use Privacy Policy

Back to Top